Skip to content
22decisions home

Research brief · HLS-20

Outcomes or Hours? How Healthcare Buys AI Services

In analysisPlanned publish date: 10 December 2026
Theme
Partners and buying
For
Procurement, CIO, CFO
The decision
Do we buy outcomes or hours?

Summary

Do we buy outcomes or hours? We map how healthcare and life sciences decision units approach this choice: who decides, who can veto, what AI leaders are doing differently, and what it means for the technology partners they buy from.

The short answer

In healthcare and life sciences, the decision to choose between outcome-based and time-and-materials AI services is led by procurement, but the CFO can stop it. In healthcare and life sciences, outcomes such as time saved in documentation or trial operations are measurable, but liability shapes the terms. A typical large healthcare and life sciences organisation involves around 11.1 executives in AI decisions.

Key questions

  • Do healthcare and life sciences organisations prefer outcome-based or time-and-materials AI services?
  • Who decides the commercial model, and who approves it?
  • Where do outcome-based contracts work best?
  • What does this mean for services firms' pricing?

What the full report covers

  • Who is involved in this decision, who decides, and who can say no
  • How AI leaders approach it differently from laggards
  • What technology leaders should do next
  • What it means for the technology and services partners they buy from

Full report: 8 to 10 pages, PDF.

Evidence basis

  • Calibrated model
  • Cited

How we label evidence is explained in our methodology.

Frequently asked questions

Who decides how to choose between outcome-based and time-and-materials AI services in healthcare and life sciences?
In our decision-rights model, procurement decides, with input from the wider decision unit (Calibrated model).
Who can veto it?
The CFO can approve or block the decision (Calibrated model).
How much are healthcare and life sciences companies hiring for AI?
AI roles make up 1.2% of current job postings at large US healthcare and life sciences companies, with 69 senior AI roles and 7 AI-governance roles (Measured, October 2026).

Get it first

This brief is planned for 10 December 2026. Request early access and we'll send it to you as soon as it is ready.

The same decision in other industries

More from Healthcare & Life Sciences

Get our research in your inbox

One considered briefing a month on how organisations decide on, buy and adopt AI. Unsubscribe at any time.